logo
AR
Anupam Rama
Analyst at J.P. Morgan
USA
Ticker Coverage
ALXN
Sector Coverage
Earnings Call Transcripts
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram Presents Limb-Girdle Muscular Dystrophy Type 2E Functional Results (Transcript)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Limb-Girdle Muscular Dystrophy Type 2E Functional Results Call October 4, 2019 08:00 AM ET Company Participants Ian Est
Published: Oct 4 2019
Would you like to be included in the directory? Let us know!
exchange@streetcontxt.com
© Street Contxt. All Rights Reserved.
Privacy